EUR 60,90
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days. 185.
Da: Majestic Books, Hounslow, Regno Unito
EUR 65,42
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: California Books, Miami, FL, U.S.A.
EUR 69,15
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 68,87
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 62,64
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Books Puddle, New York, NY, U.S.A.
EUR 76,42
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New. 1st edition NO-PA16APR2015-KAP.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 75,85
Convertire valutaQuantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 68,86
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 71,38
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Editore: Chapman and Hall/CRC 2021-09, 2021
ISBN 10: 1032177020 ISBN 13: 9781032177021
Lingua: Inglese
Da: Chiron Media, Wallingford, Regno Unito
EUR 67,86
Convertire valutaQuantità: 10 disponibili
Aggiungi al carrelloPF. Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 77,87
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 93,37
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
EUR 94,55
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 532 pages. 9.18x6.12x1.20 inches. In Stock.
EUR 97,24
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
EUR 99,20
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
EUR 61,45
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 142,31
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days. 185.
EUR 143,18
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dr. Mani Lakshminarayanan is a researcher and statistical consultant with more than 30 years of experience in the pharmaceutical industry. He has published over 50 articles, technical reports, and book chapters besides serving as a refer.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 155,22
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. New. book.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 54,62
Convertire valutaQuantità: 5 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Da: moluna, Greven, Germania
EUR 56,83
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Dr. Mani Lakshminarayanan is a researcher and statistical consultant with more than 30 years of experience in the pharmaceutical industry. He has published over 50 articles, technical reports, and book chapters besides serving as a refer.
Da: PBShop.store US, Wood Dale, IL, U.S.A.
EUR 78,72
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 72,32
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 94,14
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The cost for bringing new medicine from discovery to market has nearly doubled in the last decade and has now reached $2.6 billion. There is an urgent need to make drug development less time-consuming and less costly. Innovative trial designs/ analyses such as the Bayesian approach are essential to meet this need. This book will be the first to provide comprehensive coverage of Bayesian applications across the span of drug development, from discovery, to clinical trial, to manufacturing with practical examples.This book will have a wide appeal to statisticians, scientists, and physicians working in drug development who are motivated to accelerate and streamline the drug development process, as well as students who aspire to work in this field. The advantages of this book are:Provides motivating, worked, practical case examples with easy to grasp models, technical details, and computational codes to run the analysesBalances practical examples with best practices on trial simulation and reporting, as well as regulatory perspectivesChapters written by authors who are individual contributors in their respective topicsDr. Mani Lakshminarayanan is a researcher and statistical consultant with more than 30 years of experience in the pharmaceutical industry. He has published over 50 articles, technical reports, and book chapters besides serving as a referee for several journals. He has a PhD in Statistics from Southern Methodist University, Dallas, Texas and is a Fellow of the American Statistical Association.Dr. Fanni Natanegara has over 15 years of pharmaceutical experience and is currently Principal Research Scientist and Group Leader for the Early Phase Neuroscience Statistics team at Eli Lilly and Company. She played a key role in the Advanced Analytics team to provide Bayesian education and statistical consultation at Eli Lilly. Dr. Natanegara is the chair of the cross industry-regulatory-academic DIA BSWG to ensure that Bayesian methods are appropriately utilized for design and analysis throughout the drug-development process.